Derma Sciences Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Derma Sciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011158
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Derma Sciences Inc (Derma Sciences) is a medical devices company. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate dressing, aquasite hydrogel, primacol hydrocolloid, hydrocell foam and primaderm wound cleanser. The company’s traditional wound care products include sponges; wound dressings; packing; island and barrier border gauze; non-adherent impregnated; conforming bandages; elastic net dressings; compression bandages; protective products; tapes and laparotomy sponges. It offers solutions to acute care, extended care, home health care, wound and burn care clinics and physician offices. Derma Science markets its products through direct sales force in the US and Canada. In foreign markets, its products are marketed through various licensing and distribution agreements. It has offices, manufacturing and distribution facilities in Missouri and Texas in the US, Canada, the UK and China. Derma Sciences is headquartered in Princeton, New Jersey, the US.

Derma Sciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Derma Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Derma Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Derma Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Derma Sciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Derma Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Derma Sciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Derma Sciences Amends Licensing Agreement With Quick-Med Technologies 10
Spineology Enters Into Distribution Agreement With BioDlogics 11
Derma Sciences Enters Into Licensing Agreement With BioD For Amniotic Membrane Wound Care Products 12
Equity Offering 13
Derma Sciences Raises USD2.3 Million in Private Placement of Shares 13
Derma Sciences Completes Public Offering Of Shares For US$86.3 Million 14
Derma Sciences Completes Public Offering Of Shares For US$36 Million 16
Derma Sciences Completes Private Placement Of Common Stock For US$20 Million 18
Derma Sciences Completes Private Placement For US$29 Million 20
Acquisition 22
Integra LifeSciences to Acquire Derma Sciences in Tender Offer 22
Derma Sciences Acquires BioD 24
Derma Sciences Acquires MedEfficiency, Wound Care Management Company, For US$14.5 Million 26
Derma Sciences Inc – Key Competitors 27
Derma Sciences Inc – Key Employees 28
Derma Sciences Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 10, 2016: Derma Sciences Reports 2016 Third Quarter Financial Results 30
Aug 09, 2016: Derma Sciences Reports 2016 Second Quarter Financial Results 32
May 11, 2016: Derma Sciences Reports 2016 First Quarter Financial Results 34
Mar 16, 2016: Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results 36
Jan 07, 2016: Derma Sciences Provides 2015 Preliminary Net Sales and Introduces 2016 Financial Guidance 38
Corporate Communications 39
Aug 18, 2016: Derma Sciences Names Russell Olsen President of Advanced Wound Care 39
Product News 40
03/07/2016: Findings from Multicenter Study Comparing Derma Sciences’ AMNIOEXCEL Against Standard-of-Care for Treating Diabetic Foot Ulcers Published in WOUNDS, a Leading Peer-Reviewed Journal 40
03/03/2016: Derma Sciences’ AMNIOEXCEL Now Eligible for Reimbursement by Medicare Administrative Contractor WPS 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Derma Sciences Inc, Medical Equipment, Key Facts, 2015 2
Derma Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Derma Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Derma Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Derma Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Derma Sciences Inc, Deals By Market, 2011 to YTD 2017 8
Derma Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Derma Sciences Amends Licensing Agreement With Quick-Med Technologies 10
Spineology Enters Into Distribution Agreement With BioDlogics 11
Derma Sciences Enters Into Licensing Agreement With BioD For Amniotic Membrane Wound Care Products 12
Derma Sciences Raises USD2.3 Million in Private Placement of Shares 13
Derma Sciences Completes Public Offering Of Shares For US$86.3 Million 14
Derma Sciences Completes Public Offering Of Shares For US$36 Million 16
Derma Sciences Completes Private Placement Of Common Stock For US$20 Million 18
Derma Sciences Completes Private Placement For US$29 Million 20
Integra LifeSciences to Acquire Derma Sciences in Tender Offer 22
Derma Sciences Acquires BioD 24
Derma Sciences Acquires MedEfficiency, Wound Care Management Company, For US$14.5 Million 26
Derma Sciences Inc, Key Competitors 27
Derma Sciences Inc, Key Employees 28
Derma Sciences Inc, Subsidiaries 29

★海外企業調査レポート[Derma Sciences Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glycotope GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company’s expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of anti …
  • UCB SA (UCB)-製薬・医療分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • MMC Norilsk Nickel:企業のM&A・事業提携・投資動向
    MMC Norilsk Nickel - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MMC Norilsk Nickel Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Valero Energy Corporation:企業の戦略・SWOT・財務情報
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Arsenal Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Steven Madden Ltd (SHOO):企業の財務・戦略的SWOT分析
    Steven Madden Ltd (SHOO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Healthsense Inc-医療機器分野:企業M&A・提携分析
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • University of Alberta-製薬・医療分野:企業M&A・提携分析
    Summary University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and cla …
  • Fresh Del Monte Produce Inc.:企業の戦略・SWOT・財務情報
    Fresh Del Monte Produce Inc. - Strategy, SWOT and Corporate Finance Report Summary Fresh Del Monte Produce Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Synthetic Biologics Inc (SYN):企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • The Manitowoc Company Inc:企業の戦略・SWOT・財務情報
    The Manitowoc Company Inc - Strategy, SWOT and Corporate Finance Report Summary The Manitowoc Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Essar Power Ltd:企業の戦略的SWOT分析
    Essar Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Century Aluminum Co:企業の戦略・SWOT・財務情報
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Greystone Logistics Inc (GLGI):企業の財務・戦略的SWOT分析
    Summary Greystone Logistics Inc (Greystone Logistics) is a chemical company that manufactures plastic pallet products. The company provides products such as no rods pallet, rods pallet, beverage pallet, nestable pallet, monoblock pallet, rackable pallet, picture frame web-top pallets, stackable pall …
  • Mahagenco:企業の戦略的SWOT分析
    Mahagenco - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務分析
    National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆